Search Results - "O’B Hourihane, Jonathan"

The Role of Shared Decision Making in Pediatric Food Allergy Management by Anagnostou, Aikaterini, Hourihane, Jonathan O’B., Greenhawt, Matthew

“…Shared decision making was first highlighted in a report by the Institute of Medicine in 2001. The primary aim of this initiative was to improve the quality of…”
Get full text

Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year by Kennedy, Elizabeth A., BS, Connolly, Jennifer, MSc, Hourihane, Jonathan O'B., DM, Fallon, Padraic G., PhD, McLean, W.H. Irwin, DSc, FRS, Murray, Deirdre, PhD, Jo, Jay-Hyun, PhD, Segre, Julia A., PhD, Kong, Heidi H., MD, MHSc, Irvine, Alan D., MD, DSc

“…Background Disease flares of established atopic dermatitis (AD) are generally associated with a low-diversity skin microbiota and Staphylococcus aureus…”
Get full text

Formula supplementation remains a risk for cow's milk allergy in breast‐fed infants by Kelly, Eimear, DunnGalvin, Gillian, Murphy, Brendan P., O’B Hourihane, Jonathan, Ebisawa, Motohiro

“…Background Many breastfed babies in Ireland receive formula supplementation within 24 hours of birth. We explored (a) impact of formula supplementation on the…”
Get full text

A virtual management approach to infant egg allergy developed in response to pandemic‐imposed restrictions by Mac Mahon, Jayne, Hourihane, Jonathan O’B, Byrne, Aideen

Get full text

No evidence of isotretinoin sensitization in peanut-allergic children: a cross-sectional study by Ruth, Emma, Heraghty, Fionnuala, Flynn, Niamh, McGlynn, Triona, Turner, Paul J, Kelleher, Maeve, Byrne, Aideen, O’B. Hourihane, Jonathan

“…The European Medicines Agency (EMA) advises that all medicines containing soya-derived excipients should be labelled as contraindicated in peanut-allergic…”
Get full text

Anaphylaxis in children and adolescents: The European Anaphylaxis Registry by Grabenhenrich, Linus B., MD, MPH, Dölle, Sabine, PhD, Moneret-Vautrin, Anne, MD, Köhli, Alice, MD, Lange, Lars, MD, Spindler, Thomas, MD, Ruëff, Franziska, MD, Nemat, Katja, MD, Maris, Ioana, MD, Roumpedaki, Eirini, MD, Scherer, Kathrin, MD, Ott, Hagen, MD, Reese, Thomas, MD, Mustakov, Tihomir, MD, Lang, Roland, PhD, Fernandez-Rivas, Montserrat, MD, Kowalski, Marek L., MD, PhD, Bilò, Maria B., MD, Hourihane, Jonathan O'B., MD, Papadopoulos, Nikolaos G., MD, Beyer, Kirsten, MD, Muraro, Antonella, MD, Worm, Margitta, MD

“…Background Anaphylaxis in children and adolescents is a potentially life-threatening condition. Its heterogeneous clinical presentation and sudden occurrence…”
Get full text

BSACI 2021 guideline for the management of egg allergy by Byrne, Aideen, Kelleher, Maeve M, Hourihane, Jonathan O’B

Get full text

ASQ-3 and BSID-III’s concurrent validity and predictive ability of cognitive outcome at 5 years by Duggan, Cian, Irvine, Alan D., O’B Hourihane, Jonathan, Kiely, Mairead E., Murray, Deirdre M.

“…Background Early detection of cognitive disability is challenging. We assessed the domain-specific, concurrent validity of the ages and stages questionnaire…”
Get full text

Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year by Kelleher, Maeve, MB, Dunn-Galvin, Audrey, PhD, Hourihane, Jonathan O'B., DM, Murray, Deirdre, MD, Campbell, Linda E., BSc, McLean, W.H. Irwin, DSc, FRS, Irvine, Alan D., MD

“…Background Loss-of-function mutations in the skin barrier protein filaggrin ( FLG ) are a major risk for atopic dermatitis (AD). The pathogenic sequence of…”
Get full text

Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy by Brown, Sara J., MD, Asai, Yuka, MD, Cordell, Heather J., DPhil, Campbell, Linda E., MSc, Zhao, Yiwei, MD, PhD, Liao, Haihui, MD, PhD, Northstone, Kate, PhD, Henderson, John, MD, Alizadehfar, Reza, MD, Ben-Shoshan, Moshe, MD, Morgan, Kenneth, PhD, Roberts, Graham, DM, Masthoff, Laury J.N., MD, Pasmans, Suzanne G.M.A., MD, PhD, van den Akker, Peter C., MD, Wijmenga, Cisca, PhD, Hourihane, Jonathan O’B., PhD, Palmer, Colin N.A., PhD, Lack, Gideon, PhD, Clarke, Ann, MD, MSc, Hull, Peter R., MD, PhD, Irvine, Alan D., MD, McLean, W. H. Irwin, PhD, DSc

“…Background IgE-mediated peanut allergy is a complex trait with strong heritability, but its genetic basis is currently unknown. Loss-of-function mutations…”
Get full text

Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy by Hourihane, Jonathan O'B., MD, DM, Allen, Katrina J., MD, PhD, Shreffler, Wayne G., MD, PhD, Dunngalvin, Gillian, PhD, Nordlee, Julie A., MS, Zurzolo, Giovanni A., PhD, Dunngalvin, Audrey, PhD, Gurrin, Lyle C., PhD, Baumert, Joseph L., PhD, Taylor, Steve L., PhD

“…Background Eliciting doses (EDs) of allergenic foods can be defined by the distribution of threshold doses for subjects within a specific population. The ED05…”
Get full text

Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials by Brown, Kari R., Baker, James, Vereda, Andrea, Beyer, Kirsten, Burks, A. Wesley, du Toit, George, O’B Hourihane, Jonathan, Jones, Stacie M., Norval, David, Dana, Adrian, Shreffler, Wayne, Vickery, Brian P., Casale, Thomas, Skeel, Ben, Adelman, Daniel

“…Peanut (Arachis hypogaea) allergen powder-dnfp (PTAH; previously known as AR101) is a daily oral immunotherapy approved to mitigate allergic reactions after…”
Get full text

Managing Food Allergy When the Patient Is Not Highly Allergic by Sicherer, Scott H., Abrams, Elissa M., Nowak-Wegrzyn, Anna, Hourihane, Jonathan O’B.

“…Few patients with food allergy are “highly allergic,” meaning they always have severe reactions and always react to very small amounts of allergen. Standard…”
Get full text

Don’t put all your eggs (and milk) in one basket by Kelleher, Maeve M., Trujillo, Juan, Byrne, Aideen, O’B Hourihane, Jonathan

Get full text

How much is too much? Threshold dose distributions for 5 food allergens by Ballmer-Weber, Barbara K., MD, Fernandez-Rivas, Montserrat, MD, PhD, Beyer, Kirsten, MD, Defernez, Marianne, PhD, Sperrin, Matthew, PhD, Mackie, Alan R., PhD, Salt, Louise J., PhD, Hourihane, Jonathan O'B., MD, Asero, Riccardo, MD, Belohlavkova, Simona, MD, Kowalski, Marek, MD, PhD, de Blay, Frédéric, MD, Papadopoulos, Nikolaos G., MD, PhD, Clausen, Michael, MD, Knulst, André C., MD, PhD, Roberts, Graham, DM, Popov, Ted, MD, PhD, Sprikkelman, Aline B., MD, PhD, Dubakiene, Ruta, DRmed Habil, Vieths, Stefan, PhD, van Ree, Ronald, PhD, Crevel, René, DIBT, Mills, E.N. Clare, PhD

“…Background Precautionary labeling is used to warn consumers of the presence of unintended allergens, but the lack of agreed allergen thresholds can result in…”
Get full text

A longitudinal study of hymenoptera stings in preschool children by Clifford, Danielle, Ni Chaoimh, Carol, Stanley, Eve, O’B Hourihane, Jonathan, Ebisawa, Motohiro

“…Background Insect venom is the second most common cause of anaphylaxis outside of medical encounters. Stings cause over 20% of all anaphylactic deaths and 7%…”
Get full text

Calculating the effect of population-level implementation of the Learning Early About Peanut Allergy (LEAP) protocol to prevent peanut allergy by O'Connor, Cathal, MB, Kelleher, Maeve, MD, O'B Hourihane, Jonathan, FRCPI, DM

“…Fifty-three (3.0%) of 1745 BASELINE children were sensitized to egg with skin prick test (SPT) responses of 3 mm or greater before 12 months of age.5 At formal…”
Get full text

Neonatal adiposity increases the risk of atopic dermatitis during the first year of life by O'Donovan, Sinéad M., PhD, O'B. Hourihane, Jonathan, MD, Murray, Deirdre M., PhD, Kenny, Louise C., PhD, Khashan, Ali S., PhD, Chaoimh, Carol ní, PhD, Irvine, Alan D., MD, Kiely, Mairead, PhD

“…Background Early nutrition and adiposity have been linked to atopic dermatitis (AD) development. Objective We sought to describe risk factors for AD in the…”
Get full text

Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic by Lyons, Daniel, Murray, Cliodhna, Hannigan, Siobhan, Sui, Jacklyn, Alamin, Salma, Conlon, Niall, Keogan, Mary, Khalib, Khairin, Fitzpatrick, Chris, O’B Hourihane, Jonathan, Carey, Michael, Edgar, J David M

“…Anaphylaxis is a rare side-effect of COVID-19 vaccines. To (a) provide direct advice and reassurance to certain persons with a history of anaphylaxis/complex…”
Get full text

Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens by Westerhout, Joost, Baumert, Joseph L., Blom, W. Marty, Allen, Katrina J., Ballmer-Weber, Barbara, Crevel, René W.R., Dubois, Anthony E.J., Fernández-Rivas, Montserrat, Greenhawt, Matthew J., Hourihane, Jonathan O'B., Koplin, Jennifer J., Kruizinga, Astrid G., Le, Thuy-My, Sampson, Hugh A., Shreffler, Wayne G., Turner, Paul J., Taylor, Steve L., Houben, Geert F., Remington, Benjamin C.

“…Food allergies are a significant public health issue, and the only effective management option currently available is strict avoidance of all foods containing…”
Get full text